HEADER ISOMERASE/ISOMERASE INHIBITOR 29-MAY-15 5BQI TITLE DISCOVERY OF A POTENT AND SELECTIVE MPGES-1 INHIBITOR FOR THE TITLE 2 TREATMENT OF PAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROSTAGLANDIN E SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MICROSOMAL GLUTATHIONE S-TRANSFERASE 1-LIKE 1,MGST1-L1, COMPND 5 MICROSOMAL PROSTAGLANDIN E SYNTHASE 1,MPGES-1,P53-INDUCED GENE 12 COMPND 6 PROTEIN; COMPND 7 EC: 5.3.99.3; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTGES, MGST1L1, MPGES1, PGES, PIG12; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS MPGES-1, ENZYME, INTEGRAL MEMBRANE PROTEIN, TARGETNAME, ISOMERASE- KEYWDS 2 ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.J.FISHER,M.A.SCHIFFLER,S.L.KUKLISH,S.ANTONYSAMY,J.G.LUZ REVDAT 3 06-MAR-24 5BQI 1 HETSYN REVDAT 2 29-JUL-20 5BQI 1 COMPND JRNL REMARK HETNAM REVDAT 2 2 1 SITE REVDAT 1 13-APR-16 5BQI 0 JRNL AUTH M.A.SCHIFFLER,S.ANTONYSAMY,S.N.BHATTACHAR,K.M.CAMPANALE, JRNL AUTH 2 S.CHANDRASEKHAR,B.CONDON,P.V.DESAI,M.J.FISHER,C.GROSHONG, JRNL AUTH 3 A.HARVEY,M.J.HICKEY,N.E.HUGHES,S.A.JONES,E.J.KIM, JRNL AUTH 4 S.L.KUKLISH,J.G.LUZ,B.H.NORMAN,R.E.RATHMELL,J.R.RIZZO, JRNL AUTH 5 T.W.SENG,S.J.THIBODEAUX,T.A.WOODS,J.S.YORK,X.P.YU JRNL TITL DISCOVERY AND CHARACTERIZATION OF 2-ACYLAMINOIMIDAZOLE JRNL TITL 2 MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 INHIBITORS. JRNL REF J.MED.CHEM. V. 59 194 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26653180 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01249 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1105 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.88 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1507 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.69 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.2360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1174 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 115 REMARK 3 SOLVENT ATOMS : 74 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.66000 REMARK 3 B22 (A**2) : 0.66000 REMARK 3 B33 (A**2) : -2.14000 REMARK 3 B12 (A**2) : 0.33000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.096 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.090 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.271 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1355 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1842 ; 1.044 ; 2.013 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 157 ; 3.961 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 50 ;39.750 ;21.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 203 ;13.194 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;11.822 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 210 ; 0.062 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 986 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 602 ;16.704 ;46.158 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 752 ;13.478 ;71.033 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 752 ;14.968 ;59.128 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2147 ;15.414 ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000210366. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 93.15 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : .97931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20694 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 19.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.80000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS HCL PH 8.5 + 33% PEG 2000 REMARK 280 MME + 100MM POTASSIUM THIOCYANATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.16750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.03602 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.18700 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 38.16750 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 22.03602 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 41.18700 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 38.16750 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 22.03602 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.18700 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.07203 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 82.37400 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 44.07203 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 82.37400 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 44.07203 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 82.37400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 363 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 370 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 ALA A 0 REMARK 465 LEU A 1 REMARK 465 PRO A 2 REMARK 465 ALA A 3 REMARK 465 HIS A 4 DBREF 5BQI A 2 152 UNP O14684 PTGES_HUMAN 2 152 SEQADV 5BQI MET A -1 UNP O14684 INITIATING METHIONINE SEQADV 5BQI ALA A 0 UNP O14684 EXPRESSION TAG SEQADV 5BQI LEU A 1 UNP O14684 EXPRESSION TAG SEQRES 1 A 154 MET ALA LEU PRO ALA HIS SER LEU VAL MET SER SER PRO SEQRES 2 A 154 ALA LEU PRO ALA PHE LEU LEU CYS SER THR LEU LEU VAL SEQRES 3 A 154 ILE LYS MET TYR VAL VAL ALA ILE ILE THR GLY GLN VAL SEQRES 4 A 154 ARG LEU ARG LYS LYS ALA PHE ALA ASN PRO GLU ASP ALA SEQRES 5 A 154 LEU ARG HIS GLY GLY PRO GLN TYR CYS ARG SER ASP PRO SEQRES 6 A 154 ASP VAL GLU ARG CYS LEU ARG ALA HIS ARG ASN ASP MET SEQRES 7 A 154 GLU THR ILE TYR PRO PHE LEU PHE LEU GLY PHE VAL TYR SEQRES 8 A 154 SER PHE LEU GLY PRO ASN PRO PHE VAL ALA TRP MET HIS SEQRES 9 A 154 PHE LEU VAL PHE LEU VAL GLY ARG VAL ALA HIS THR VAL SEQRES 10 A 154 ALA TYR LEU GLY LYS LEU ARG ALA PRO ILE ARG SER VAL SEQRES 11 A 154 THR TYR THR LEU ALA GLN LEU PRO CYS ALA SER MET ALA SEQRES 12 A 154 LEU GLN ILE LEU TRP GLU ALA ALA ARG HIS LEU HET 4UL A 201 35 HET GSH A 202 20 HET BOG A 203 20 HET BOG A 204 20 HET PG4 A 205 13 HET 1KA A 206 7 HETNAM 4UL 2-(DIFLUOROMETHYL)-5-{[(2-METHYLPROPANOYL) HETNAM 2 4UL AMINO]METHYL}-N-{5-METHYL-4-[4-(TRIFLUOROMETHYL) HETNAM 3 4UL PHENYL]-1H-IMIDAZOL-2-YL}PYRIDINE-3-CARBOXAMIDE HETNAM GSH GLUTATHIONE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 1KA (2-HYDROXYETHOXY)ACETALDEHYDE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 4UL C23 H22 F5 N5 O2 FORMUL 3 GSH C10 H17 N3 O6 S FORMUL 4 BOG 2(C14 H28 O6) FORMUL 6 PG4 C8 H18 O5 FORMUL 7 1KA C4 H8 O3 FORMUL 8 HOH *74(H2 O) HELIX 1 AA1 SER A 5 SER A 9 5 5 HELIX 2 AA2 ALA A 12 LYS A 42 1 31 HELIX 3 AA3 ASN A 46 HIS A 53 1 8 HELIX 4 AA4 GLY A 55 CYS A 59 5 5 HELIX 5 AA5 ASP A 62 PHE A 91 1 30 HELIX 6 AA6 ASN A 95 GLY A 119 1 25 HELIX 7 AA7 PRO A 124 HIS A 151 1 28 CISPEP 1 ALA A 123 PRO A 124 0 0.71 CRYST1 76.335 76.335 123.561 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013100 0.007563 0.000000 0.00000 SCALE2 0.000000 0.015127 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008093 0.00000 CONECT 1204 1222 CONECT 1205 1206 1234 1235 CONECT 1206 1205 1209 CONECT 1207 1208 1211 1212 CONECT 1208 1207 1231 CONECT 1209 1206 1210 CONECT 1210 1209 1211 1233 CONECT 1211 1207 1210 1232 CONECT 1212 1207 CONECT 1213 1214 CONECT 1214 1213 1215 1216 CONECT 1215 1214 CONECT 1216 1214 1217 1227 CONECT 1217 1216 1218 CONECT 1218 1217 1219 CONECT 1219 1218 1220 1226 CONECT 1220 1219 1221 CONECT 1221 1220 1222 CONECT 1222 1204 1221 1223 CONECT 1223 1222 1224 1225 CONECT 1224 1223 CONECT 1225 1223 CONECT 1226 1219 1227 CONECT 1227 1216 1226 1228 CONECT 1228 1227 1229 1230 CONECT 1229 1228 CONECT 1230 1228 1231 CONECT 1231 1208 1230 1232 CONECT 1232 1211 1231 CONECT 1233 1210 1234 CONECT 1234 1205 1233 CONECT 1235 1205 1236 1237 1238 CONECT 1236 1235 CONECT 1237 1235 CONECT 1238 1235 CONECT 1239 1240 CONECT 1240 1239 1241 1244 CONECT 1241 1240 1242 1243 CONECT 1242 1241 CONECT 1243 1241 CONECT 1244 1240 1245 CONECT 1245 1244 1246 CONECT 1246 1245 1247 1248 CONECT 1247 1246 CONECT 1248 1246 1249 CONECT 1249 1248 1250 1252 CONECT 1250 1249 1251 1254 CONECT 1251 1250 CONECT 1252 1249 1253 CONECT 1253 1252 CONECT 1254 1250 1255 CONECT 1255 1254 1256 CONECT 1256 1255 1257 1258 CONECT 1257 1256 CONECT 1258 1256 CONECT 1259 1260 1261 1268 CONECT 1260 1259 1271 CONECT 1261 1259 1262 1263 CONECT 1262 1261 CONECT 1263 1261 1264 1265 CONECT 1264 1263 CONECT 1265 1263 1266 1267 CONECT 1266 1265 CONECT 1267 1265 1268 1269 CONECT 1268 1259 1267 CONECT 1269 1267 1270 CONECT 1270 1269 CONECT 1271 1260 1272 CONECT 1272 1271 1273 CONECT 1273 1272 1274 CONECT 1274 1273 1275 CONECT 1275 1274 1276 CONECT 1276 1275 1277 CONECT 1277 1276 1278 CONECT 1278 1277 CONECT 1279 1280 1281 1288 CONECT 1280 1279 1291 CONECT 1281 1279 1282 1283 CONECT 1282 1281 CONECT 1283 1281 1284 1285 CONECT 1284 1283 CONECT 1285 1283 1286 1287 CONECT 1286 1285 CONECT 1287 1285 1288 1289 CONECT 1288 1279 1287 CONECT 1289 1287 1290 CONECT 1290 1289 CONECT 1291 1280 1292 CONECT 1292 1291 1293 CONECT 1293 1292 1294 CONECT 1294 1293 1295 CONECT 1295 1294 1296 CONECT 1296 1295 1297 CONECT 1297 1296 1298 CONECT 1298 1297 CONECT 1299 1300 CONECT 1300 1299 1301 CONECT 1301 1300 1302 CONECT 1302 1301 1303 CONECT 1303 1302 1304 CONECT 1304 1303 1305 CONECT 1305 1304 1306 CONECT 1306 1305 1307 CONECT 1307 1306 1308 CONECT 1308 1307 1309 CONECT 1309 1308 1310 CONECT 1310 1309 1311 CONECT 1311 1310 CONECT 1312 1313 1314 CONECT 1313 1312 CONECT 1314 1312 1315 CONECT 1315 1314 1316 CONECT 1316 1315 1317 CONECT 1317 1316 1318 CONECT 1318 1317 MASTER 287 0 6 7 0 0 0 6 1363 1 115 12 END